Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Ravnskov

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Medical Hypotheses|October 1, 1989
Non-systemic glomerulonephritis: exposure to nephro- and immunotoxic chemicals predispose to immunologic harassmentU Ravnskov
Lancet (London, England)|November 5, 1994
What do angiographic changes after cholesterol lowering mean?U Ravnskov
Lakartidningen|December 4, 2001
[Lipid lowering doesn't affect the development of atherosclerosis in peripheral artery disease]U Ravnskov
QJM : Monthly Journal of the Association of Physicians|May 31, 2002
Is atherosclerosis caused by high cholesterol?U Ravnskov
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1988
Focal glomerular lesions in glomerulonephritis may be secondary to tubulointerstitial damageU Ravnskov
The New England Journal of Medicine|March 11, 1976
Letter: Serum beta2-microglobulin and glomerular functionU Ravnskov
Circulation|September 1, 1993
Coronary atherosclerosis on angiography--progress or regress, and why?U Ravnskov
BMJ (Clinical Research Ed.)|April 16, 1994
Ischaemic heart disease and cholesterol. Optimism about drug treatment is unjustifiedU Ravnskov
Ugeskrift for Laeger|August 1, 1994
[Uncritical review of articles on cholesterol]U Ravnskov
Medical Hypotheses|November 1, 1991
An elevated serum cholesterol level is secondary, not causal, in coronary heart diseaseU Ravnskov
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Medical Hypotheses|October 1, 1989
Non-systemic glomerulonephritis: exposure to nephro- and immunotoxic chemicals predispose to immunologic harassmentU Ravnskov
Lancet (London, England)|November 5, 1994
What do angiographic changes after cholesterol lowering mean?U Ravnskov
Lakartidningen|December 4, 2001
[Lipid lowering doesn't affect the development of atherosclerosis in peripheral artery disease]U Ravnskov
QJM : Monthly Journal of the Association of Physicians|May 31, 2002
Is atherosclerosis caused by high cholesterol?U Ravnskov
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1988
Focal glomerular lesions in glomerulonephritis may be secondary to tubulointerstitial damageU Ravnskov
The New England Journal of Medicine|March 11, 1976
Letter: Serum beta2-microglobulin and glomerular functionU Ravnskov
Circulation|September 1, 1993
Coronary atherosclerosis on angiography--progress or regress, and why?U Ravnskov
BMJ (Clinical Research Ed.)|April 16, 1994
Ischaemic heart disease and cholesterol. Optimism about drug treatment is unjustifiedU Ravnskov
Ugeskrift for Laeger|August 1, 1994
[Uncritical review of articles on cholesterol]U Ravnskov
Medical Hypotheses|November 1, 1991
An elevated serum cholesterol level is secondary, not causal, in coronary heart diseaseU Ravnskov
Pageof 10